Next Article in Journal
A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept
Next Article in Special Issue
Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
Previous Article in Journal
The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments
Pharmaceuticals 2010, 3(1), 42-58; doi:10.3390/ph3010042
Article

Role of Glycogen Synthase Kinase-3β in APP Hyperphosphorylation Induced by NMDA Stimulation in Cortical Neurons

1
, 1
, 1
, 2
, 3
, 3
, 1
, 1
 and 1,*
Received: 23 October 2009; in revised form: 3 December 2009 / Accepted: 5 January 2010 / Published: 7 January 2010
(This article belongs to the Special Issue Protein Kinase Inhibitors)
View Full-Text   |   Download PDF [366 KB, uploaded 11 January 2010]   |   Browse Figures
Abstract: The phosphorylation of Amyloid Precursor Protein (APP) at Thr668 plays a key role in APP metabolism that is highly relevant to AD. The c-Jun-N-terminal kinase (JNK), glycogen synthase kinase-3β (GSK-3β) and cyclin-dependent kinase 5 (Cdk5) can all be responsible for this phosphorylation. These kinases are activated by excitotoxic stimuli fundamental hallmarks of AD. The exposure of cortical neurons to a high dose of NMDA (100 μM) for 30’-45’ led to an increase of P-APP Thr668. During NMDA stimulation APP hyperphosphorylation has to be assigned to GSK-3β activity, since addition of L803-mts, a substrate competitive inhibitor of GSK-3β reduced APP phosphorylation induced by NMDA. On the contrary, inhibition of JNK and Cdk5 with D-JNKI1 and Roscovitine respectively did not prevent NMDA-induced P-APP increase. These data show a tight connection, in excitotoxic conditions, between APP metabolism and the GSK-3β signaling pathway.
Keywords: APP; NMDA; GSK-3β; JNK; Cdk5 APP; NMDA; GSK-3β; JNK; Cdk5
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Ploia, C.; Sclip, A.; Colombo, A.; Repici, M.; Gardoni, F.; Di Luca, M.; Forloni, G.; Antoniou, X.; Borsello, T. Role of Glycogen Synthase Kinase-3β in APP Hyperphosphorylation Induced by NMDA Stimulation in Cortical Neurons. Pharmaceuticals 2010, 3, 42-58.

AMA Style

Ploia C, Sclip A, Colombo A, Repici M, Gardoni F, Di Luca M, Forloni G, Antoniou X, Borsello T. Role of Glycogen Synthase Kinase-3β in APP Hyperphosphorylation Induced by NMDA Stimulation in Cortical Neurons. Pharmaceuticals. 2010; 3(1):42-58.

Chicago/Turabian Style

Ploia, Cristina; Sclip, Alessandra; Colombo, Alessio; Repici, Mariaelena; Gardoni, Fabrizio; Di Luca, Monica; Forloni, Gianluigi; Antoniou, Xanthi; Borsello, Tiziana. 2010. "Role of Glycogen Synthase Kinase-3β in APP Hyperphosphorylation Induced by NMDA Stimulation in Cortical Neurons." Pharmaceuticals 3, no. 1: 42-58.


Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert